Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Viral Mutations00:36

Viral Mutations

39.6K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.6K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

49.2K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.2K
Size and Structure of Viral Genomes01:26

Size and Structure of Viral Genomes

646
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
646

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Seroprevalence of hepatitis C virus infection among individuals attending a private clinic in Luanda, Angola.

BMC infectious diseases·2026
Same author

HIV-1 late diagnosis in Cabo Verde: associated factors and implications for preventive strategies.

Frontiers in epidemiology·2026
Same author

Optimizing HIV-1 Genotypic Resistance Testing for Low- and Middle-Income Countries: High-Impact HIV-1 Mutations Across WHO-Defined Scenarios.

Viruses·2026
Same author

Protocol for generating human iPSC-derived cardiomyocytes using VCAM1-based sorting and micropatterned culture.

STAR protocols·2026
Same author

Orthographic Knowledge as a Predictor of Writing Composition in European Portuguese: A Longitudinal Study in Grade 2.

Behavioral sciences (Basel, Switzerland)·2026
Same author

Shaping the founders: naïve CD4 T cell heterogeneity in people with HIV-1 or HIV-2.

Frontiers in immunology·2026

相关实验视频

Updated: Jan 11, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.3K

艾滋病毒综合酶耐药性的新兴模式

Margarida Veloso1, Marta Ribeiro1, Joaquim Cabanas1

  • 1Molecular Biology Laboratory (SPC, Unidade Local de Saúde Lisboa Ocidental-HEM), Lisbon.

AIDS (London, England)
|November 14, 2025
PubMed
概括
此摘要是机器生成的。

在葡萄牙,在5.5%的HIV感染者中发现了整合酶耐药性突变,这些人经历了治疗失败. 随着整合酶抑制剂变得越来越普遍,持续监测至关重要.

更多相关视频

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

16.1K
Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses
11:19

Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses

Published on: May 4, 2015

11.7K

相关实验视频

Last Updated: Jan 11, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.3K
A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

16.1K
Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses
11:19

Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses

Published on: May 4, 2015

11.7K

科学领域:

  • 传染性疾病 传染性疾病
  • 病毒学 病毒学
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 整合酶抑制剂对于控制艾滋病毒感染至关重要.
  • 经过治疗的艾滋病毒感染者 (PWH) 具有病毒学失败,有发展抗药性的风险.
  • 新出现的耐药性需要持续监测.

研究的目的:

  • 评估葡萄牙治疗经验丰富的PWH病毒学失败的整合酶耐药突变的患病率.
  • 确定常见的整合酶抗性突变及其关联.
  • 在增加整合酶抑制剂使用的背景下,为治疗策略提供信息.

主要方法:

  • 对来自837名经过治疗的PWH的基因型耐药性数据的回顾性分析.
  • 在2022年至2024年期间在葡萄牙收集的数据.
  • 分析包括识别主要的整合酶抗性突变和HIV亚型.

主要成果:

  • 在5.5%的研究人群中检测到主要的整合酶耐药性突变.
  • N155H和R263K是最常见的突变.
  • 耐药性在非B型HIV亚型中更为普遍,并且经常与对其他类别的抗逆转录病毒药物耐药性同时发生.

结论:

  • 虽然整合酶耐药性的患病率目前很低,但需要继续监测.
  • 这些发现强调了监测耐药性的重要性,以指导使用多卢特格拉维尔,比克特格拉维尔和卡博特格拉维尔等整合酶抑制剂.
  • 了解耐药性模式对于优化长期艾滋病治疗结果至关重要.